Brighton Jones’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Brighton Jones's NBIX Position: Q3 2026 in Review
Brighton Jones reduced its Neurocrine Biosciences (NBIX) stake by 27% in Q3 2026, selling an estimated $554K and leaving 9,381 shares worth $1.33M. The position accounts for 0.02% of the portfolio, ranked #417.
Brighton Jones first reported a position in NBIX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.49M in Q1 2026. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Brighton Jones held 9,381 shares of Neurocrine Biosciences worth $1.33M as of Q3 2026.
- Brighton Jones sold 3,449 Neurocrine Biosciences shares in Q3 2026, an estimated $554K.
- Neurocrine Biosciences made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #417 holding.
- Brighton Jones first reported a position in Neurocrine Biosciences in Q2 2025 and has held it in 5 quarters since.
- Brighton Jones's Neurocrine Biosciences position peaked at $2.49M in Q1 2026.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.